Abstract
Introduction
Structure and function of voltage-gated Ca 2+ channels have been analyzed in great detail during the last two decades [1, 2] . This paves way for the molecular dissection of related inherited diseases called channelopathies [3] [4] [5] [6] [7] . Detecting interacting proteins in large scale even extends the molecular view to large networks of proteins which are important for normal function and may be involved in several disease states [8] .
The ion conducting Ca v α1 subunits of high-voltage activated non-L-type Ca 2+ channels share a high degree of structural similarity within the conserved transmembrane domains. But their interconnecting II-III loops are structurally highly divergent. Within this region, splice variants of Ca v 2.3 differ by an arginine-rich segment which is conferring a unique Ca 2+ -sensitivity to the major neuronal Ca v 2.3 splice variants [9] [10] [11] . The increasing cytosolic Ca 2+ concentration serves as a positive feedback signal for Ca v 2.3 E-type Ca 2+ channels. We assumed that Ca 2+ -sensitive proteins might interact with the II-IIIloop of Ca v 2.3, because a direct binding of cytosolic Ca 2+ to the positively charged arginine-rich segment is very unlikely. As the novel Ca 2+ -sensitivity of neuronal Ca v 2.3 subunits was detected in the Ca v 2.3 transfected human embryonic kidney cell line (HEK-293), the same cell system was used to identify interaction partners by immunoprecipitation of the over-expressed FLAG-tagged II-III loop. This approach led to the detection of hsp70 as a novel interaction partner which was functionally tested in Ca v 2.3 stably transfected HEK-293 cells and during ex vivo retinal signal transduction. Further, it was found that the immunopurified II-III loop of Ca v 2.3 stimulates autophosphorylation of protein kinase C.
It will be discussed that the interaction complex identified so far may involve additional scaffold proteins providing specificity for the observed phorbol ester effects on extended neuronal Ca v 2.3c and Ca v 2.3d splice variants containing the exon 19 encoded arginine-rich segment within the II-III loop [9] [10] [11] .
Materials and Methods
Materials 15-Deoxyspergualin was from Nippon Kayaku (Tokyo, Japan). L-α-Phosphatidyl-L-Serine, phorbol 12-myristate 13-acetate, the FLAG tagged immunoprecipitation kit and other chemicals were from Sigma (München, Germany). The antimyc antibody was purchased from Invitrogen (Karlsruhe/ Germany, catalogue number R950-25) and was diluted for western blots 1:5000 as recommended by the company. PKCα was purchased as purified protein from Calbiochem (Merck Biosciences, Schwalbach, Germany), and was over-expressed in HEK-293 cells using the pPKCα-EGFP vector from Clontech (Heidelberg, Germany). The bicistronic mammalian expression vector, pIRES-hrGFP-1a, was purchased from Stratagene (Amsterdam, The Netherlands), and the vector providing an in-frame myc epitope, pcDNA3.1/myc-His, was from Invitrogen (Karlsruhe, Germany). The restriction enzymes were purchased from Fermentas GmbH (St. Leon-Rot, Germany).
DNA-vectors
The full length cDNA of Ca v 2.3 was cloned from fetal brain [12] . It corresponds to the splice variant Ca v 2.3d (α 1Ed , GenBank # L27745) which was subcloned into the pcDNA3 vector for transient or stable expression in HEK-293 cells [13] . The deletions of amino acids in Ca v 2.3d to generate Ca v 2.3e and related mutants were made by a double step overlap extension PCR [14] . The splice variant Ca v 2.3e detected in INS-1 cells [15] , lacks only the last 19 aas encoded by nts 2299 -2355 (see Fig. 1 ).
The full length II-III -loop construct was amplified from the Ca v 2.3d-pcDNA3 vector [13] with forward primer containing the Not I site and Kozak sequence (5'-ATGCGGCCGCCCACCATGGATAATCTCGCCAACGCCCAG-3'), and the reverse primer containing a Sal I site (5'-ACGTCGACGGCGCAGGTTCACGAT-3'). It was digested with Not I and Sal I, and subcloned into pIRES-hrGFP-1a yielding pIRES-hrGFP-1a-α1E-II-III loop. Further, the Not I -Sal I fragment was also subcloned into pBluescript-SK to be used as a template to generate shorter II-III -loop variants. The Pst I -Bpu1102 I fragments from pBSK-fα1E∆ins1 [9;10] , from pBSK-fα1E-1/2Rdel and from pBSK-fα1E-Rdel [9, 10] were subcloned into the Pst I -Bpu1102 I digested pBSK-α1E-II-IIIloop vector. The Not I -Sal I fragments obtained from last three intermediate vectors were subcloned into the Not I -Sal I digested pIRES-hrGFP-1a vector yielding the final constructs used for transfection into HEK-293 cells, the vectors pIREShrGFP-1a-α1E-II-III-loop-∆Ex19 (= Ca v 2.3e), pIRES-hrGFP-1a-α1E-II-III-loop-∆1/2Rdel (= ∆R20), and pIRES-hrGFP-1a-α1E-II-III-loop-∆Rdel (=∆R19∆R20), respectively.
The carboxyl terminus of each II-III loop-segment was fused to three FLAG-epitopes, (N-Asp-Tyr-Lys-Asp-Asp-AspAsp-Lys-C) 3 , for immunoprecipitation [16, 17] .
Clones containing A2B56 phosphatase and hsp70 were purchased from the Research Center Berlin (Deutsches Resourcenzentrum für Genomforschung, GmbH). The coding sequence for hsp70 was amplified from clone IRALp962O0740 using Hind III site containing forward primer, 5'-CCC AAG CTT CCC GCC GCC GCC ATG GCC AAA GCC GCG GCG ATC-3' and Xho I site containing reverse primer, 5'-AAC TCG AGC CAT CCA CCT CCT CAA TGG TAG G-3'. The cDNA-fragment was digested with Hind III and Xho I, and subcloned into pcDNA3.1/ myc-His. PKCα was amplified from a commercially available vector (Clontech, Heidelberg, Germany) and subcloned in the same way. The constructs were sequenced using standard methods.
Transfection of HEK-293 cells
For voltage clamp recordings, HEK-293 cells were transfected with the vectors of interest and a vector expressing the enhanced green fluorescent protein (EGFP) using the calcium-phosphate precipitation technique (Stratagene, Amsterdam, The Netherlands). For the patch-clamp studies, all variants of Ca v 2.3-α1 subunits were expressed in the pcDNA3 vector.
For immunoprecipitation, HEK-293 cells were transfected with different vector constructs containing variants of the II-III -loop from Ca v 2.3 and pIRES-hrGFP-1a vector backbone was used as a control (see Fig. 1B and: [9, 10] ).
Immunoprecipitation of the FLAG-tagged protein and phosphorylation
The II-III -loop was cloned into the pIRES-hrGFP-1a vector in frame with 3 consecutive FLAG-tags. The transfected HEK 293 cells were lysed using a buffer consisting of (mM): Tris HCl, 50 (pH 7.4); NaCl, 150; EDTA, 1; Triton X-100, 1 % (v/ v). The FLAG-tagged proteins were isolated by affinity chromatography using anti-FLAG agarose matrix, according to the instructions of the manufacturer (product number FLAGIPT-1, Sigma, Munich). All steps were performed at 4°C. The bound FLAG-fusion proteins were eluted either with the denaturing sample buffer for interaction studies, or with the 3X FLAG peptide solution (product number F4799, 150 ng/µl final peptide concentration) for the phosphorylation assays.
Tagged proteins were phosphorylated in vitro by PKCα (Calbiochem) using gamma 32 P-ATP [16] . The reaction was started by addition of 2 nM PKCα and stopped after 30 min by addition of denaturing sample buffer. Incorporated 32 P was analyzed after SDS/PAGE by autoradiography.
Western blotting HEK-293 cells were grown as described [14] . Proteins were separated by polyacrylamide gel electrophoresis according to standard protocols and were immunoblotted as reported previously [14] . The ECL detection kit was purchased from Amersham Corp. (Braunschweig, Germany).
Mass spectrometry
Reflectron MALDI-TOF mass spectrometry was performed in the central service of the Center for Molecular Medicine (Köln), on a Bruker Reflex III or IV instrument (Bruker Daltonik, Bremen, Germany) in the positive ion mode using a pulsed laser beam (nitrogen laser, λ = 337 nm). The acceleration voltage was set to 20 kV, and the reflector voltage was 22.5 kV.
Voltage-clamp recordings
Membrane currents from transfected HEK-293 cells were recorded in the tight-seal whole-cell configuration of the patch clamp technique [10, 11] 
Data analysis and curve fitting
Current amplitudes and kinetics were recorded as reported [10] . Inactivation kinetics of the currents were estimated by fitting the decaying part of the current traces with the equation: I(t) = a o + a 1 * exp(-(t-x)/τ 1 ). The data are expressed as mean ± SEM, and n is the number of cells used. Statistical significance was analysed using Student's t-test and levels of p < 0.05 were considered as statistically significant.
ERG recordings from the isolated superfused bovine retina [18] Bovine retina was isolated and perfused with a nutrient solution, which either contained the drug of interest or lactose the excipient for control [19, 20] .
Eyes were removed from a calf in the local slaughterhouse and immediately stored in an empirically optimized nutrient solution consisting of (in mM): 120 NaCl, 2.0 KCl, 0.15 CaCl 2 , 0.1 MgCl 2 , 1.5 NaH 2 PO 4 , 13.5 Na 2 HPO 4 , and 5 glucose with a final pH of 7.8. Eyes were hemisected at the junction of sclera and cornea followed by removal of lens and vitreous body from the posterior eyecup. Using a 7 mm trephine, circular pieces were obtained from the posterior segment, which had been divided into four sclera-choroid-retina segments prior to extraction. Subsequently, the retina was detached from the underlying pigment epithelium by gentle shaking. Plain retina segments from calf were then transferred to a chamber sandwiched between a mesh and an O-ring, and finally transferred to a perfusion chamber located in an electrically and optically insulated box [18] . The whole preparation was carried out under dim red illumination. Prior to experiments the retina was continuously superfused on both sides using flow system fed from a reservoir at a flow rate of 1 ml/min. Temperature was kept constant at 30°C, and the perfusion medium was preequilibrated and saturated with oxygen.
Following retinal dark adaptation, the ERG was elicited by a single white flash at intervals of 5 min. The flash intensity at the retinal surface was set to 6.3 mlx using calibrated neutral density filters. Light stimulation lasting for 500 ms was controlled by a timer operating mechanical shutter system. To avoid 50 Hz noise, the heater was shut down during light stimulation and ERG recording. The ERG was amplified and bandpass limited between 1 and 300 Hz. The signal was AD converted and stored using a PC-based signal acquisition and analysis system. NiCl 2 was added from a 10 mM stock solution. Drug [12] , and the Ca v 2.3c variant is the major Ca v 2.3 transcript found in cerebrum while the Ca v 2.3e variant is expressed in cerebellum, heart and in endocrine tissues [14, 15] . Note, that the splice variants expressing exon 19 (insert R19) were shown to be modulated by cytosolic Ca 2+ [9;10] . Note, exon 19 encodes the full R19 insert but R20 is only encoded by the first 57 nts of exon 20. B.) Vector constructs for the over-expression of FLAGtagged II-III loop segments from Ca v 2.3. B1) Cartoon of the pIRES-hrGFP-1a vector showing the insertion positions.B2) Dimensions of the individual segments from the II-III loop which were fused in frame to a triple FLAG-epitope for immunoprecipitation.
application was initiated after the b-wave had reached a stable amplitude, followed by a recovery period of at least 60 min. The b-wave amplitude was measured from the trough of the a-wave to the peak of the b-wave.
Results

Search for protein binding partners of cytosolic II-III loops from Ca v 2.3 splice variants
To understand the Ca 2+ and phorbol ester mediated stimulation of Ca v 2.3 E-type Ca 2+ channels, different II-III loops of Ca v 2.3 splice variants, either containing or lacking the exon 19 encoded arginine rich segment (R19), were over-expressed in HEK-293 cells. Further, two mutants were generated (Fig. 1) . The immunopurified proteins were resolved on a polyacrylamide gel (Fig. 2 ). Two polypeptides larger than 100 kDa, and another one with 45 kDa were present in all aliquots loaded on the gels including aliquots from the untreated beads ( Fig. 2 ) which was identified by using anti-FLAG antibodies (not shown). Based on the primary sequence of the full length II-III loop (1347 nts) and the fused segments, a molecular weight of 54 kDa was calculated which is lower than the apparent size of the FLAG-tagged full length II-III -loop (66 kDa). This maybe due to glycosylation or electrostatic interactions of the highly charged FLAG-tags with the polyacrylamide matrix.
In parallel, HEK-293 cells were transfected with the shorter variant of the II-III loop, lacking R19 (Fig. 2 , lane 6). From mock transfected cells (Fig. 2 , lane 2), a 72 kDa polypeptide observed in lane 3 to 6 was also coimmunoprecipitated leading to the conclusion, that this one is unrelated and that the 79 kDa sized polypeptide from the full length loop of Ca v 2.3d (Fig. 2, upper arrow, lane 3) may represent a specific interaction partner for the co-immunoprecipitated II-III loop of neuronal Ca v 2.3 splice variants. As the precipitated 79 kDa polypeptide resembles the size of PKCα and because the 79 kDa protein was easily detected by Coomassie blue staining, its band was excised and trypsin digested for mass spectrometry. Proteins were identified from the resulting mass spectra using the commercially available search engine Mascot® (Matrix Sciences, London, UK). Two polypeptide-bands were identified by the matrix-assisted laser desorption/ionization -time of flight -mass spectrometry (MALDI-TOF-MS). None of the two peptides represented any PKC fragment. The 66 kDa protein was identical with the human II-III -loop of Ca v 2.3, and the 79 kDa polypeptide was indicative of the human heat shock 70 kDa protein 1A (hsp70) (Tab. 1). From this peptide, the masses of 29 tryptic peptides matched with published hsp70 sequences leading to a total score of 133. In conclusion, hsp70 was detected as a novel interaction partner of Ca v 2.3 II-III loop, but not the prime candidate PKC which is known to activate Ca v 2.3 induced currents , and which may be responsible for the Ca 2+ dependent effects on inactivation and recovery from inactivation [10, 11] .
Both II-III loops of neuronal and endocrine/ cardiac Ca v 2.3 co-immunoprecipitate with hsp70.
To confirm the direct binding of hsp70 to Ca v 2.3-II-III loop, we used another independent approach. PKCα and hsp70 were subcloned into a vector containing a C-terminal myc -tag. These vectors were co-transfected in HEK-293 cells either with one of the two different FLAG-tagged II-III -loop constructs or with the cytosolic carboxyl terminal domain of Ca v 2.3 (corresponding to nts 5169 -6936, GenBank L27745). After 72 hours, the transfected cells were lysed, and the II-III -loop protein partners were immunoprecipitated and analyzed by SDS-PAGE (Fig. 3) . For PKCα (Fig. 3, lane 4-6) , non-specific proteins were detected larger than 100 kDa, as with the Tab. 1. MALDI_TOF analysis of the two major polypeptides separated by PAGE. Both identified proteins show a slower electrophoretic mobility than predicted by their primary sequences which might be explained by electrophoretic interactions caused by the FLAG-tag of the II-III -loop segment.
other putative partners (Fig. 3, lanes 1-3 and 7-9) . Also the polypeptide of 90 kDa in the PKCα-experiments (Fig. 3, lane 5,6 ) must be regarded as non-specific, because it was co-immunoprecipitated with the mock vector, too (Fig. 3, lane 4) . Therefore, no specific protein of the expected size was precipitated with the full length II-III loop co-transfected with PKCα or the control protein phosphatase-subunit PP2A. However, the c-myc-tagged hsp70 was co-immunoprecipitated with both II-III loops (Fig. 3, lane 8 and 9 ), but not with the over-expressed carboxyl terminal domain of Ca v 2.3 (not shown) leading to the conclusion that hsp70 but not PKCα -is indeed a direct interaction partner of Ca v 2.3. Further, hsp70 coimmunoprecipitates with the II-III loops of both Ca v 2.3 splice variants (Fig. 3, lane 7 and 8 ) although such a 70 kDa polypeptide was not observed in large amounts in the Coomassie-stained gel (Fig. 2) , suggesting, that the affinity of the two different Ca v 2.3 II-III loops to hsp70 might differ.
Effect of 15-deoxyspergualin (DSG) on Ca v 2.3 mediated calcium currents
DSG is a synthetic analogue of spergualin, which was originally isolated from the culture filtrate of Bacillus laterosporus [22] . It inhibits the nuclear translocation of activated NF-kappaB through heat shock proteins, and reduces the cytoplasmic expression of hsp70 [23] . Assuming that DSG may interact with hsp70, DSG (5 µM) was applied to the external bath solution during patch clamp recordings of Ca 2+ inward currents from Ca v 2.3d transfected HEK-293 cells. At 5 µM, DSG significantly reduced the current density from 13.9 ± 1.7 pA/pF to 8.3 ± 1.4 pA/pF (n = 11 cells, p = 0.03), a reduction that turned out to be irreversible during subsequent washout suggesting that DSG restrains hsp70 from Ca 2+ channel. Under control conditions with equivalent amounts of lactose, an excipient for DSG, peak I Ca remained unchanged at 13.5 ± 1.6 pA/pF and 12.6 ± 1.1 pA/pF, respectively (n = 5 cells, p = 0.6).
From previous experiments in Ca v 2.3-transfected HEK-293 cells, it was known that incoming Ca 2+ reduces the inactivation of the channel when switching the charge carrier from Ba 2+ to Ca 2+ [10] . Therefore we calculated fast and slow inactivation components in 5 mM Ca 2+ . The decaying parts of the Ca 2+ current traces were approximated using an exponential fit [9] [10] [11] (Fig. 4A) . The time constants were compared before and after application of drugs ( Fig. 4B and 4C ). In lactose, the fast inactivation time constant (τ fast ) was increased from 43 ± 5 ms to 56 ± 6 ms (n = 5), whereas in DSG, τ fast was decreased from 30 ± 3 ms to 27 ± 3 ms (n = 11). The τ fast values between lactose and DSG treatments was significantly different (p = 0.0001). Similarly the slow inactivation time constant (τ slow ) was slightly increased from 118 ± 6 ms to 128 ± 8 ms (n = 5) in lactose, but in DSG, τ slow was significantly decreased from 104 ± 4 ms to 89 ± 8 ms (n = 9). The τ slow value in DSG treatment was reduced significantly (p = 0.008) from that of lactose treatment. Thus, DSG reduced both fast and slow inactivation of the channel (Fig. 4B and 4C ). This observation leads to the conclusion that DSG interferes with the functional binding of hsp70 to the Ca v 2.3 E-type Ca 2+ channel.
Effect of 15-deoxyspergualin on retinal signal transduction and the Ni 2+ -sensitive stimulation of the ERG b-wave amplitude
To demonstrate the effect of DSG on II-III loop in a more physiological process, we used the isolated bovine retina as an ex vivo test system for neural transmission [18, 19] . It was selected, because the ERG-b-wave from the bovine retina contains a Ni 2+ -sensitive component which is related to Ca v 2.3 / E-type voltage-gated Ca 2+ channels [20] .
In control recordings lactose, the excipient for DSG was used (Fig. 5A) . During repetitive light stimulation (every 5 min for 0.5 sec), lactose by itself caused a 1.2-fold increase of the b-wave response (Fig. 5C ). Under The τ fast -values were determined before (hatched boxes) and 1 min after adding (black boxes) either lactose as control (lac, n = 5) or 5 µM DSG (dsg, n = 11). Decrease with DSG when compared with lactose is significant (p = 0.0001). C.) Mean of slow inactivation time constants (τ slow ). The τ slow -values were determined before (hatched boxes) and 1 min after adding (black boxes) either lactose (lac, n = 5) or 5 µM DSG (dsg, n = 9). In DSG, the difference of the τ slow -values is highly significant (p = 0,008). 20 µM DSG, the b-wave amplitude was unchanged in 4 independent experiments (Tab. 2). Further, the b-wave amplitude was increased from 19.6 ± 5.7 µV in lactose to 25.4 ± 7.3 µV in 15 µM NiCl 2 plus lactose. After washout of NiCl 2 and lactose, b-wave amplitude was completely reduced to 20.1 ± 5.8 µV. Such a complete reversal of the b-wave amplitude after washout is indicative for the E-type Ca 2+ channel and is similar to the recently reported values for a NiCl 2 mediated stimulation [20] . We have deliberately used, as the most reliable measure of the Ni 2+ -effect, its washout by the basic nutrient solution (Fig.  5D ) because lactose by itself caused a 1.2-fold increase in b-wave amplitude before NiCl 2 application (Fig. 5A) .
After equilibrating the retina with 20 µM DSG, the NiCl 2 -meditated maximum response of 29.4 ± 5.9 µV was only partially washed out to 27.1 ± 4,9 µV (n = 6) (Fig. 5B) . In comparison, the NiCl 2 -meditated increase of b-wave amplitude was significantly reduced (p = 0.006) from 1.27 fold under control conditions to 1.07-fold after DSG application (Tab. 1 and Fig. 5D ). As the Ni 2+ mediated increase was significantly higher under control recordings and completely reversible during washout (Fig.  5A) , the reduced ratio after DSG application indicates that a heat shock protein, probably hsp70, is involved in retinal signal transduction. DSG influences both, the basic retinal signalling and more intensely NiCl 2 -stimulated propagation of excitation; leading to the conclusion, that hsp70 may influence the b-wave amplitude through its interaction with Ca v 2.3. We hypothesize that hsp70 may stabilize the II-III loop or may act as a scaffold protein for protein kinase Cα (PKCα) favouring Ca v 2.3 phosphorylation.
A2
A3 A1 [10, 11] . E-type Ca 2+ channels expressing the full length II-III loop are more strongly activated than those lacking R19 (Fig. 6E) . Peak inward currents of full-length E-type channels were increased by 100 nM PDBu to 143 ± 4% (n = 12). The simultaneous truncation of both, R19 (Fig. 1) and the homologous segment adjacent to exon 20 (= R20) completely abolishes the phorbol ester mediated stimulation (99 ± 2%, n = 9) [11] . However, the deletion of only insert R19 clearly attenuates the phorbol ester meditated stimulation of peak inward currents but does not reduce it completely (106 ± 2%, n = 13).
The remaining susceptibility for phorbol ester stimulation after deletion of only R19 was investigated more in detail for the splice variant Ca v 2.3e which is expressed in heart and endocrine tissues. These experiments were performed in equimolar Ca 2+ instead of Ba 2+ . It is known that the full length Ca v 2.3d splice variant which was stably expressed in HEK293 cells, is maximally stimulated when Ca 2+ is used as charge carrier [11] . But, the deletion of R19 attenuates both, the kinetics for inactivation [9] and the recovery from inactivation (Fig. 7A) leading to the hypothesis that the deletion of the first arginine-rich segment (R19) might severely reduce the affinity for PKC. To test this hypothesis, exogenous PKCα was coexpressed with Ca v 2.3e in HEK-293 cells using the pPKCα-EGFP vector. The overexpression of PKCα leads to a faster recovery from inactivation in the absence (Fig. 7B ) and the presence of phorbol ester (Fig. 7C) , in the Ca v 2.3e splice variant lacking R19. This finding supports our assumption that the apparent affinity of the Ca v 2.3e for a PKC interaction differs between those variants lacking or containing R19.
In conclusion, these data lead to the suggestion that both native occurring splice variants are modulated by phorbol esters, but to a different extent.
Autophosphorylation of PKCα is stimulated by the II-III loops of Ca v 2.3.
According to the literature, Ca v 2.2 (N-type) α1 subunits are regulated by PKC dependent phosphorylation of the cytosolic linker connecting domain I and II [24] . Similarly, Ca v 2.3 currents are potentiated by PKCdependent phosphorylation, which is stimulated by muscarinic receptor activation. Several potential PKC phosphorylation sites are common between the Ca v 2.1 and Ca v 2.2 channels, but some are unique to Ca v 2.3 leading to the suggestion that Ca v 2.3 is in addition activated through phosphorylation sites in the carboxy terminal domain of the channel protein [25] . When analysing the phorbol ester mediated stimulation of Ca v 2.3, we and others [25] found that the II-III -loop is an important determinant for phorbol ester-mediated activation of Ca v 2.3 recorded as increase in peak inward current (Fig.  6) . As phorbol esters activate PKC, we assumed initially a direct phosphorylation of the II-III -loop. However, none of the different constructs of the II-III -loop was phosphorylated by exogenously added PKCα which should have led to phosphoproteins of 62 to 66 kDa ( ). E. The ratio of peak inward current 2 min after bath application of 100 nM PDBu to that one without phorbol ester is plotted for the neuronal variant, for two different mutants and for the endocrine splice variant Ca v 2.3e lacking exon 19 encoded R19. The full length II-III loop of neuronal Ca v 2.3d is mutated by deletion to Ca v 2.3∆R19∆R20 lacking 38 amino acids. The second mutant Ca v 2.3R20 is lacking R20, while the native splice variant Ca v 2.3e is lacking insert R19. the added PKCα itself, which was detected as a phosphoprotein with an identical molecular size when the eluate from mock transfected cells was added to the phosphorylation assay or when no protein homogenate from HEK-293 cells was introduced to the assay system (Fig. 8B, lane 1 and 11) . If any of the four different II-III -loop constructs was used for transfection and the immunopurified protein was added to the phosphorylation assay, the autophosphorylation of the 75 kDa protein, supposed to be PKCα, was dramatically increased. Even more, if no exogenous PKC was added, a polypeptide of A polypeptide with the same electrophoretic mobility as hsp70 was not detected in our co-immunoprecipitation assays with truncated II-III loops (Fig. 3, lane 4) assuming that the affinity of the tested loops differs dramatically. The data suggest that autophosphorylation of PKCα is highly stimulated by the presence of any of the II-III loop In conclusion, hsp70 interacts with the II-III loop of Ca v 2.3, at the biochemical and functional level. Further, PKCα does not directly bind to Ca v 2.3 but it may mediate its stimulatory effect through hsp70, a known PKCinteracting protein [26, 27] .
Discussion
In HEK-293 cells, the in vivo charge carrier Ca 2+ modulates at physiological concentrations the kinetics of Ca v 2.3 induced inward currents by Ca 2+ accumulation inside the cells [10] . This process is different from the Ca 2+ dependent inactivation, which is also known for Ca v 2.3 [28] , and which occurs at more elevated intracellular Ca 2+ levels. Initially, when Ca 2+ has entered the cells through Ca v 2.3, it slows down inactivation and fastens recovery from inactivation of the recorded Ba 2+ inward currents [9, 10] . In vivo, the Ca 2+ dependent modulation of E-type Ca 2+ channels may lead to a faster recruitment of neuronal Ca v 2.3c or Ca v 2.3d Ca 2+ -channels during long term potentiation in the CA3 region of hippocampus [29] .
Based on the comparison of in vivo occurring splice variants, we found that the novel Ca 2+ -dependent activation of neuronal Ca v 2.3c and Ca v 2.3d variants is dependent on structural determinants in the II-III loop, the exon 19 encoded arginine-rich segment (R19) [9] . The Ca 2+ -sensitivity of Ca v 2.3d which leads to the stimulation of I Ba and to the reported changes in kinetics, is strongly attenuated, but not completely abolished, when R19 was removed, as it is accomplished in the so called "endocrine splice variant" Ca v 2.3e [15] .
The Ca 2+ -mediated effects on the activity of Ca v 2.3 / E-type channels resemble the effects on Ca v 2.3 mediated by phorbol esters [11] . As observed with increasing cytosolic [Ca 2+ ], phorbol ester stimulation is also dependent on the exon 19. Therefore we assume, that PKC interacts directly or indirectly with the II-III loop of Ca v 2.3 as it was proposed by Kamatchi and coworkers [25] . Based on the results of the present study, hsp70 binds directly to the neuronal and endocrine II-III loops of Ca v 2.3, and is functionally interacting with retinal neurotransmission. Further, PKCα as a classical Ca 2+ activated protein kinase does not directly bind to the II-III loop of Ca v 2.3, and one may speculate, that hsp70 mediates the binding of PKC to the II-III loop to support phosphorylation of the channel protein.
The interaction of hsp70 with Ca Fig. 9 . Proposed interaction of hsp 70, protein kinase C, and different variants of the II-III -loop. The model of interaction has to account for at least four different facts: (i) The II-III -loops of both splice variants co-immunoprecipitate with substantial amounts of the hsp70 protein (note, hsp70 is bound to the channel in all four panels).
(ii) Only the Ca v 2.3 channel with the full length loop is highly Ca 2+ -sensitive which is caused by its higher sensitivity towards phorbol esters, and causes its slowing of inactivation and acceleration of recovery from inactivation (situation in panel B). (iii) The chaperone hsp70 is well known to interact with cysteine string proteins as syntaxin, synaptotagmin and SNAP-25 [37] . Synaptotagmin functionally interacts with Ca v 2.3d containing E-/ R-type voltage-gated Ca 2+ channels recruiting the protein complex to the plasma membrane of Xenopus oocytes which only would be possible according to panel B [34, 35] . Micromolar [Ca 2+ ] inside the cells influences the channel kinetics more potently when Ca v 2.3 subunits containing a full length II-III -loop are expressed in HEK-293 cells [10] . Only when hsp70 interacts with the full length loop, it can keep PKC active for a longer time. The deletion of exon 19 encoded R19 in the endocrine splice variant causes nearly a complete loss of Ca 2+ sensitivity (panel C and D) which can be overcome by over-expression of PKCα (not shown).
has been summarized recently [27] . When PKC is activated, it is highly sensitive towards dephosphorylation. Hsp70 is able to bind to the dephosphorylated turn motif of PKC and stabilizes it. PKC becomes rephosphorylated and is able to re-enter the pool of signalling-competent PKC. If hsp70 is missing, dephosphorylated PKC accumulates in a detergent-insoluble cell fraction and is degraded [26, 27] .
As hsp70 was shown to co-immunoprecipitate with the II-III -loop of Ca v 2.3 after over-expression in HEK-293 cells, such kind of a PKC stimulation may occur during the phorbol ester and Ca 2+ mediated modulation of transfected Ca v 2.3 [11] and activated PKC could interact indirectly with the II-III loop of Ca v 2.3 by using the hsp70 as an adaptor protein. The differences of the electrophysiological results observed with the different II-III loop constructs [9] [10] [11] could be caused by a different affinity of the two II-III loops to hsp70, which then may indirectly influence the phosphorylation rate of PKC. This assumption is supported by the observation that a 79 kDa protein is mainly found after transfection of the full length but not with shorter variants of II-III loops (see Fig. 2 ). Also the observation that over-expression of PKCα changes the kinetics of Ca v 2.3e to that of Ca v 2.3d (see Fig. 7 ) points to differences in affinities for interaction A B C D partners of the various II-III loops which can be compensated by a higher expression level of PKCα in HEK-2C6 cells. Alternate factors may also be considered as for example the competitive interaction with auxiliary subunits [21] , although we have shown that the cotransfection of the ß-subunit is not necessary to demonstrate the phorbol ester effects on Ca v 2.3 [11] .
A direct phosphorylation of the cytosolic II-III loop by PKC probably can be excluded because after in vitro phosphorylation of immunoaffinity purified II-III -loop no other major phosphoprotein was detected except the autophosphorylated exogenous PKCα itself, leading to the suggestion that the hsp70-bound II-III loop increases the activity of PKC by its association. When we compare the extent of the PKC autophosphorylation by the different II-III loops in vitro, the truncated II-III -loops stimulate autophosphorylation to the same extent as the full length II-III -loop, suggesting that a selective stimulation of autophosphorylation is not only defined by the II-III -loop structure or depend on the presence or absence of the arginine-rich segment, but also dependent on additional factors. Further, it is known from the literature that the PKC activity is modulated by arginine-rich peptides [30] . The results with hsp70 showing functional interaction, and the effect of purified hsp70 -II-III loop on autophosphorylation support the idea that additional unknown factors may cause the more selective stimulation of inward currents observed by Ca 2+ and phorbol esters for the full length neuronal II-III loop of Ca v 2.3 in HEK-293 cells.
Based on the present results and on the reported interactions of Ca v 2.3 with synaptic vesicle proteins, it is presumed that for the full length II-III loop a trimeric complex may associate to activate PKC maximally including an unknown interaction partner X which provides the selectivity of the Ca 2+ -and PKC-dependent activation of the neuronal II-III loop (Fig. 9A, B) . The most favourite candidate as an additional interaction partner is synaptotagmin for three major reasons: (i) it is one of those cysteine string proteins which acts as a known co-chaperone for hsp70 [31] , (ii) it is a substrate for PKC [32] and most importantly, (iii) synaptotagmin is that synaptic vesicle protein, which interacts with E-/R-type Ca 2+ channels in a Ca 2+ -selective manner [33] [34] [35] . The other possible candidate, syntaxin-1A, does not functionally interact with full length Ca v 2.3 in HEK-293 cells [9] . In conclusion, insert R19 may confer an increased Ca 2+ -sensitivity to Ca v 2.3 through its interaction with synaptotagmin or another partner X (Fig. 9A, B) .
The detailed interaction of Ca v 2.3 and hsp70 is by far not yet completely understood and rather speculative for the membrane-bound full-length channel. So far, we can demonstrate, that the II-III loop is an important determinant for PKC signalling, thus phosphorylating other regions of the E-type Ca 2+ channel protein for an increased activation, and that hsp70 is an important docking partner involved in this process. As hsp70 is also involved in the modulation of apoptosis, ischemic heart disease, diabetes and neurodegeneration [36] , the understanding of this mechanism for E-type Ca 2+ channel regulation will be important to unravel the recently discovered role of Ca v 2.3 in apoptosis and juvenile myoclonic epilepsy [6, 38] .
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Ca v 2.3 (ion conducting α1 subunit of E-type voltagegated Ca 2+ channels); DSG (15-deoxyspergualin); ERG (electroretinogram); hsp70 (heat shock 70 kDa protein 1A); PKC (protein kinase C); PDBu (phorbol-12,13-dibutyrate); FLAG (a fusion tag consisting of eight amino acids (DYKDDDDK) including an enterokinasecleavage site); (c)-myc (a fusion tag consisting of 11 amino acids (EQKLISEEDL)).
